DE112010005017A5 - Beta-carboline zur behandlung von hörschäden und schwindel - Google Patents
Beta-carboline zur behandlung von hörschäden und schwindel Download PDFInfo
- Publication number
- DE112010005017A5 DE112010005017A5 DE112010005017T DE112010005017T DE112010005017A5 DE 112010005017 A5 DE112010005017 A5 DE 112010005017A5 DE 112010005017 T DE112010005017 T DE 112010005017T DE 112010005017 T DE112010005017 T DE 112010005017T DE 112010005017 A5 DE112010005017 A5 DE 112010005017A5
- Authority
- DE
- Germany
- Prior art keywords
- carboline
- beta
- difficulty
- treatment
- hearing damage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- AIFRHYZBTHREPW-UHFFFAOYSA-N β-carboline Chemical compound N1=CC=C2C3=CC=CC=C3NC2=C1 AIFRHYZBTHREPW-UHFFFAOYSA-N 0.000 title 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102009060811.7 | 2009-12-28 | ||
| DE102009060811 | 2009-12-28 | ||
| US28239510P | 2010-02-02 | 2010-02-02 | |
| US61/282,395 | 2010-02-02 | ||
| PCT/DE2010/001530 WO2011079841A1 (de) | 2009-12-28 | 2010-12-28 | Beta-carboline zur behandlung von hörschäden und schwindel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE112010005017A5 true DE112010005017A5 (de) | 2012-10-04 |
Family
ID=44246908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE112010005017T Withdrawn DE112010005017A5 (de) | 2009-12-28 | 2010-12-28 | Beta-carboline zur behandlung von hörschäden und schwindel |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9107914B2 (enExample) |
| EP (1) | EP2519238B1 (enExample) |
| JP (1) | JP5627705B2 (enExample) |
| KR (1) | KR20120098855A (enExample) |
| CN (1) | CN102844029A (enExample) |
| AU (1) | AU2010338669A1 (enExample) |
| BR (1) | BR112012015967B1 (enExample) |
| CA (1) | CA2785233C (enExample) |
| DE (1) | DE112010005017A5 (enExample) |
| IL (1) | IL220661A (enExample) |
| IN (1) | IN2012DN05066A (enExample) |
| MX (1) | MX2012007678A (enExample) |
| NZ (1) | NZ600478A (enExample) |
| RU (1) | RU2012132429A (enExample) |
| SG (1) | SG181599A1 (enExample) |
| WO (1) | WO2011079841A1 (enExample) |
| ZA (1) | ZA201204476B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113416187B (zh) * | 2013-03-14 | 2024-07-19 | 奥斯菲治疗有限公司 | 促进骨生长的烷基胺骆驼蓬碱衍生物 |
| DK3702443T3 (da) | 2013-03-14 | 2022-04-04 | Brigham & Womens Hospital Inc | Sammensætninger og fremgangsmåder til opformering og dyrkning af epiteliale stamceller |
| EP2853533A1 (de) * | 2013-09-29 | 2015-04-01 | Audiocure Pharma GmbH | 6-Fluor-9-methyl-ß-carbolin |
| KR102493376B1 (ko) | 2014-09-03 | 2023-01-27 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 청력 손실의 치료를 위해 내이 털세포를 생성하기 위한 조성물, 시스템, 및 방법 |
| JP2019506153A (ja) | 2016-01-08 | 2019-03-07 | マサチューセッツ インスティテュート オブ テクノロジー | 分化した腸内分泌細胞およびインスリン産生細胞の作製 |
| US11260130B2 (en) | 2016-03-02 | 2022-03-01 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV |
| US10213511B2 (en) | 2016-03-02 | 2019-02-26 | Frequency Therapeutics, Inc. | Thermoreversible compositions for administration of therapeutic agents |
| US10201540B2 (en) | 2016-03-02 | 2019-02-12 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I |
| EP3321264A1 (en) * | 2016-11-14 | 2018-05-16 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Selective inhibitors of genotoxic stress-induced ikk/nf-kb pathways |
| SG10201910821XA (en) | 2016-12-30 | 2020-01-30 | Frequency Therapeutics Inc | 1h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells |
| JP7695496B2 (ja) | 2018-08-14 | 2025-06-19 | オシフィ セラピューティクス リミティド ライアビリティ カンパニー | フルオロβ－カルボリン化合物 |
| MX2021001752A (es) | 2018-08-14 | 2021-06-23 | Osteoqc Inc | Compuestos de pirrolo-dipiridina. |
| EP3837352A1 (en) | 2018-08-17 | 2021-06-23 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating jag-1 |
| US11617745B2 (en) | 2018-08-17 | 2023-04-04 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating FOXO |
| CN112638370A (zh) | 2018-09-12 | 2021-04-09 | 霍夫耳科研究所 | 用于治疗耳蜗植入手术引起的听力损失的方法 |
| EP3772515A1 (en) * | 2019-08-09 | 2021-02-10 | Audiocure Pharma GmbH | Stable polymorphic form of 6-fluoro-9-methyl-9h-ss-carboline and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3240514A1 (de) | 1982-10-29 | 1984-05-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Ss-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| CA2140722A1 (en) | 1994-01-24 | 1995-07-25 | Joseph A. Jakubowski | Beta-carboline thromboxane synthase inhibitors |
| US20040038970A1 (en) | 1998-06-12 | 2004-02-26 | Societe De Conseils De Recherches Etd' Application Scientifiques, S.A.S. A Paris, France Corp. | Beta-carboline compounds |
| RU2233841C2 (ru) * | 1998-06-12 | 2004-08-10 | Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик Сас | Бета-карболиновые соединения, фармацевтические композиции на их основе и способы связывания, достижения агонистического/антагонистического эффекта |
| US20050137220A1 (en) * | 2003-07-23 | 2005-06-23 | Pharmacia Corporation | Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors |
| DE102007009264A1 (de) | 2007-02-26 | 2008-08-28 | Ellneuroxx Ltd. | 9-Alkyl-ß-Carboline zur Behandlung von neurodegenerativen Erkrankungen |
-
2010
- 2010-12-28 EP EP10812791.1A patent/EP2519238B1/de active Active
- 2010-12-28 KR KR1020127017073A patent/KR20120098855A/ko not_active Withdrawn
- 2010-12-28 WO PCT/DE2010/001530 patent/WO2011079841A1/de not_active Ceased
- 2010-12-28 JP JP2012546361A patent/JP5627705B2/ja active Active
- 2010-12-28 DE DE112010005017T patent/DE112010005017A5/de not_active Withdrawn
- 2010-12-28 SG SG2012042438A patent/SG181599A1/en unknown
- 2010-12-28 RU RU2012132429/04A patent/RU2012132429A/ru not_active Application Discontinuation
- 2010-12-28 BR BR112012015967A patent/BR112012015967B1/pt active IP Right Grant
- 2010-12-28 AU AU2010338669A patent/AU2010338669A1/en not_active Abandoned
- 2010-12-28 MX MX2012007678A patent/MX2012007678A/es not_active Application Discontinuation
- 2010-12-28 US US13/514,171 patent/US9107914B2/en active Active
- 2010-12-28 CN CN2010800630256A patent/CN102844029A/zh active Pending
- 2010-12-28 NZ NZ600478A patent/NZ600478A/xx unknown
- 2010-12-28 CA CA2785233A patent/CA2785233C/en active Active
-
2012
- 2012-06-07 IN IN5066DEN2012 patent/IN2012DN05066A/en unknown
- 2012-06-18 ZA ZA2012/04476A patent/ZA201204476B/en unknown
- 2012-06-26 IL IL220661A patent/IL220661A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011079841A1 (de) | 2011-07-07 |
| SG181599A1 (en) | 2012-07-30 |
| RU2012132429A (ru) | 2014-02-10 |
| IL220661A (en) | 2016-03-31 |
| JP2013515752A (ja) | 2013-05-09 |
| BR112012015967A2 (pt) | 2016-04-19 |
| AU2010338669A1 (en) | 2012-06-21 |
| IL220661A0 (en) | 2012-08-30 |
| US20130028958A1 (en) | 2013-01-31 |
| US9107914B2 (en) | 2015-08-18 |
| IN2012DN05066A (enExample) | 2015-10-09 |
| EP2519238A1 (de) | 2012-11-07 |
| MX2012007678A (es) | 2012-09-12 |
| CA2785233C (en) | 2018-10-09 |
| ZA201204476B (en) | 2014-01-29 |
| KR20120098855A (ko) | 2012-09-05 |
| BR112012015967B1 (pt) | 2019-08-27 |
| JP5627705B2 (ja) | 2014-11-19 |
| EP2519238B1 (de) | 2014-08-13 |
| CA2785233A1 (en) | 2011-06-07 |
| NZ600478A (en) | 2013-10-25 |
| CN102844029A (zh) | 2012-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE112010005017A5 (de) | Beta-carboline zur behandlung von hörschäden und schwindel | |
| IL261768B (en) | Devices and methods for tissue treatment | |
| EP2613735A4 (en) | DEVICES AND METHODS FOR THE TREATMENT OF VASCULAR ABNORMALITIES | |
| EP2278999C0 (en) | EAR PREPARATIONS FOR THE TREATMENT OF EAR DISEASES AND CONDITIONS | |
| EP2414260C0 (en) | METHOD AND MEANS FOR TREATING WASTE | |
| DE112011102047A5 (de) | Vorrichtung zur Wundbehandlung und Wundabdeckpflaster | |
| BRPI1014864A2 (pt) | "implante de processos espinhosos e métodos associados" | |
| EP2547292A4 (en) | INTERVERTEBRAL IMPLANTS AND SYSTEMS AND METHODS FOR IMPLANTATION OF A GRAFT | |
| EP2396019A4 (en) | METHOD AND COMPOSITIONS FOR TREATING SKIN | |
| EP2370593A4 (en) | METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS | |
| EP2237803A4 (en) | TREATMENT AND PROPHYLAXIS OF AMYLOSIS | |
| EP2451378A4 (en) | DEVICES AND METHODS FOR TREATING VASCULAR AND PERSONAL CONDUITS | |
| EP2540379A4 (en) | EXHAUST GAS TREATMENT SYSTEM, AND EXHAUST GAS TREATMENT METHOD | |
| GB2498121B (en) | Treatment device and method of use | |
| EP2405869A4 (en) | Obesity treatment | |
| EP2579936A4 (en) | INTRAGASTRIC DEVICE FOR TREATING OBESITY | |
| EP2661246A4 (en) | Wound or skin treatment devices and methods | |
| EP2579816A4 (en) | Implant components and methods | |
| EP2773369A4 (en) | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF BUCCAL DISEASES | |
| SI2523678T1 (sl) | Antagonisti Wnt in postopki zdravljenja | |
| EP2498853A4 (en) | PATIENT INTERFACE AND ITS ASPECTS | |
| EP2427061A4 (en) | GALLIUM FORMULATION FOR THE TREATMENT AND PREVENTION OF INFECTIOUS DISEASES | |
| EP3628326C0 (en) | METHODS AND SUBSTANCES FOR TREATING PUMP DISEASE | |
| ATE532507T1 (de) | Neramexane zur behandlung von subakuten tinnitus | |
| DE112011105826B8 (de) | Halbleitervorrichtung und Verfahren zur Herstellung selbiger |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R120 | Application withdrawn or ip right abandoned |